1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Glenn Foundation Discovery Award is a grant from the Glenn Foundation for Medical Research and the American Federation for Aging Research (AFAR) that supports pioneering biological research into the mechanisms governing normal human aging and age-related physiological decline. The program welcomes investigators from any branch of biology, including those who have not previously worked in aging research.
Up to two awards are made per year, each providing $555,000 over three years in annual installments of $185,000. Eligible applicants are full-time faculty at the rank of Assistant Professor or above at U.S. non-profit institutions, with established R01 or equivalent funding. Former Glenn Foundation Breakthrough in Gerontology awardees are not eligible.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Glenn Foundation Discovery Award - American Federation for Aging Research Ask the Expert Interviews 2025 Grantee Spotlight Interviews Dorothy Dillon Eweson Lecture Series Administrative Guidelines Things to Consider When Applying Funding Updates Newsletter by funding Grant Programs and Fellowships by guiding studies such as the FAST Initiative , the SuperAgers Initiative , and the TAME Trial by supporting the infrastructure of three NIA Initiatives and leading the Amplifying Geroscience Initiative .
Top Breakthroughs driven by AFAR Experts Delaying Disease by Targeting Aging Saving Costs by Extending Healthspan What are the Hallmarks of Aging? What is the Longevity Dividend? Why AFAR, Why Aging Research Clarence Pearson Fellowship NIA Infrastructure Support The SuperAgers Initiative Amplifying Geroscience Initiative Breakthroughs by AFAR Experts What are the Hallmarks of Aging?
What is the Longevity Dividend? Ask the Expert Interviews What is Geroscience? 2025 AFAR Awards of Distinction Glenn Foundation for Medical Research (GFMR) Discovery Award Eligibility and Selection Criteria The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award.
This Award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible.
This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline .
Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan. Up to two three-year awards will be made in 2026.
Each award is for $555,000 payable in annual installments of $185,000 per year, of which a maximum of 8% may be used for indirect expenses or institutional overhead (not to exceed $13,704 per year). Recipients of this award are expected to attend the combined AFAR Grantee Conference and Glenn Foundation Workshop on Biology of Aging in the second and third year of the award.
The purpose of the meetings is to promote scientific and personal exchanges among recent AFAR and GFMR grantees and other invited scientists in aging research. Eligibility and Selection Criteria To be eligible, the applicant: Must be a full-time faculty member at the rank of Assistant Professor or higher at the time of the LOI deadline.
A candidate at the Assistant Professor level must have established R01 or equivalent funding such as an NIH DP1, DP2, DP5, R37, R56, RF1, RL1, U01 and R35 or a VA Merit Award. Please contact grants@afar. org if you are unsure.
The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories. Must have a strong record of independent publication beyond the postdoctoral level Cannot be a Principal Investigator supported through the Paul F. Glenn Centers for Biology of Aging Research .
Must conduct the proposed research at qualified not-for-profit setting in the United States. Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging are encouraged to apply.
Former AFAR Research Grant for Junior Faculty awardees may apply; former Glenn Foundation Breakthrough In Gerontology (BIG) awardees may NOT apply. If you are applying for an AFAR Grant for Junior Faculty and Glenn Foundation for Medical Research Grants for Junior Faculty, you may NOT also apply for the 2026 Glenn Foundation Discovery Award. Questions about eligibility and suitability of research project can be addressed to grants@afar.
org . Applications are reviewed based on the following criteria: Potential of the proposed research to (i) yield new discoveries in biology applicable to human aging and healthspan, or (ii) establish new approaches for clinically relevant strategies, treatments, and therapeutics that address human aging and health span. Qualifications and research record of the applicant.
Excellence of the research environment. The Letter of Intent (“LOI”) deadline is February 18, 2026 . Please refer to the GFMR Discovery Award LOI for instructions.
Incomplete or improperly completed LOIs cannot be considered. All LOIs should be submitted as PDFs here . The Letters of Intent will be reviewed by a committee.
All LOI candidates who are invited to submit applications must have it endorsed by their institution. Neither the GFMR nor AFAR will provide reviewer critiques to any applicants at any review level.
LOI Deadline: February 18, 2026 Results LOI review: Early May 2026 Deadline to submit full application: Mid-June 2026 Award Start Date: July 1, 2026 If you are using animals in your research, we strongly encourage you to review Guidelines for Aging Rodent Research . Please review this link, Things to Consider When Submitting an Application , which includes suggestions for submitting an LOI or application to AFAR.
Click here for our Frequently Asked Questions page. Investigators will be required to submit a brief narrative report annually on the progress of their research. Final narrative and financial reports are required within three months following the end date of the award.
Glenn Foundation for Medical Research Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation for Medical Research is to extend the healthy years of life through research on mechanisms of biology that govern normal human aging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan with lifespan.
Funding Updates Newsletter McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss Who is eligible: Independent Assistant and Associate Professors Research area: Cognitive Aging and Memory Loss Amount of award: $750,000 Number of awards given: Two Deadline for Letter of Intent: April 15, 2026 Hevolution Foundation Scientific Conferences Fund Who is eligible: Non-profit organizations, public and private universities, colleges, laboratories and government agencies in North America (Canada, United States of America, and Mexico), the United Kingdom, and countries in the European Union Amount of award: Up to $10,000 per meeting Deadline: January 31, April 30, July 31, October 31 Diana Jacobs Kalman/AFAR Graduate Student Awards in Geroscience Who is Eligible: MD, DO, PhD, or combined degree students who have completed at least two years by October 1, 2026 Research Area: Geroscience and the Biology of aging Nomination Deadline: May 8, 2026 AFAR Grants for Junior Faculty and Glenn Foundation for Medical Research (GFMR) Grants for Junior Faculty Who is eligible: Independent Early Stage Investigators Research area: Biology of aging Amount of award: $160,000 Award period: 1 or 2 years Number of awards given: Approximately 10 Deadline for LOI: The deadline has passed for 2026 The Sagol Network GerOmic Award for Junior Faculty Who is eligible: Independent Junior Faculty Research area: Aging-related -omics research Amount of award: $160,000 Award period: 1 or 2 years Number of awards given: 1 Letter of Intent Deadline: The deadline has passed for 2026 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research Who is Eligible: Postdoctoral fellows Research Focus: Basic and translational research that builds on early discoveries that show translational potential for clinical relevant strategies Letter of Intent Deadline : The deadline has passed for 2026 2025 Glenn Foundation for Medical Research Postdoctoral Fellowship Continuation Awards Who is Eligible: Current or former GFMR Postdoctoral Fellows in Aging Research Research Focus: Basic and translational research that builds on early discoveries that show translational potential for clinical relevant strategies Award Amount: $80,000 (a minimum of $62,652 is to be used for salary and the remainder to be used for allowable expenses) Letter of Intent Deadline : The deadline has passed for 2026 Medical Student Training in Aging Research (MSTAR) Program Who is Eligible: Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2026.
Interested students should be in touch directly with the National Training Centers to determine their eligibility and program deadline.
Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03) Who is Eligible: Early stage investigators in AD/ADRD research and established researchers who are not currently doing AD/ADRD research Research area: Alzheimer’s Disease and Alzheimer’s Disease Related Dementias Awards Given: approximately 12 Deadlines: February 16, June 16, and October 16.
According to the current listing, eligibility includes: Full-time faculty members at the rank of Assistant Professor or higher with established R01 or equivalent funding. Open to relevant proposals from any branch of biology. Confirm the full requirements in the official notice before applying.
The current listing shows $555,000 over three years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Glenn Foundation Discovery Award is funded by Glenn Foundation for Medical Research in collaboration with the American Federation for Aging Research (AFAR). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleWith Forms J in FY2027, NIH will no longer accept letters of support — the boilerplate endorsements applicants have padded proposals with for decades. Notice NOT-OD-26-094 replaces them with letters of collaboration, aligning NIH with NSF. Here is exactly what changes, what a compliant letter must now contain, who can no longer write one, and how this fits the broader re-engineering of the NIH application package.
Read articleOMB and roughly 40 agencies have proposed the most sweeping overhaul of 2 CFR Part 200 in more than a decade. Political appointees would pre-review notices of funding opportunity and discretionary awards, agencies gain near-unappealable 'national interest' termination authority, and federal funds can no longer support collaborations with covered foreign entities. The rule drew nearly half a million comments and is slated to take effect October 1, 2026. Here is what actually changes, who is exposed, and how to write proposals that survive the new regime.
Read article